MedPath

Trial to Evaluate the Efficacy on Local Anesthesia and Safety of 2% Lidocaine HCl With Different Epinephrine Concentration in Patients Undergoing Surgical Extraction of Impacted Lower Third Molars

Phase 4
Completed
Conditions
Third Molar
Registration Number
NCT02696369
Lead Sponsor
Huons Co., Ltd.
Brief Summary

This study is Phase 4 trial which evaluates the safety and efficacy of 2% Lidocaine HCl with different epinephrine concentration in patients undergoing surgical extraction of impacted lower third molars

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Age over 19
  • Physical grade 1 or 2 by American Society of Anesthesiologists (ASA)
  • Mesioangular or horizontal angulation categorized by winter classification
Exclusion Criteria
  • Allergy or hypersensitivity about the investigated products
  • Any infection or edema during the extraction
  • The following patients: clotting disorder, hyperthyroidism, arteriosclerosis, cardiac insufficiency, other cardiovascular disorders
  • Pregnancy or breast-feeding
  • Any conditions that the investigator considers not to appropriate for this study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Pain visual analogue scale (VAS)Immediately after the extraction

To acess the pain immediately after the surgical extraction of impacted lower third molars

Secondary Outcome Measures
NameTimeMethod
Pain VAS2, 4, 6 hours after administration of the investigational product (IP)
Bleeding after extraction measured by the operatorImmediately after extraction
Local anesthetic durationImmediately after onset of anesthesia
Questionnaire of satisfaction level of the operatorImmediately after extraction
Questionnaire of satisfaction level of the subjectsImmediately after extraction
Dosage of administrated IPimmediately after injection
Onset time of anesthesiaImmediately after administration of IP
Onset time of pain after administration of IPImmediately after injection

Trial Locations

Locations (1)

Huons

🇰🇷

Ansan, Kyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath